US Stock MarketDetailed Quotes

RDHL Redhill Biopharma

Watchlist
  • 6.500
  • +0.030+0.46%
Close Dec 20 16:00 ET
  • 6.690
  • +0.190+2.92%
Post 20:01 ET
8.29MMarket Cap-0.02P/E (TTM)

Redhill Biopharma Key Stats

Redhill Biopharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2022/Q412.798M / 18.100M--
--2022/Q317.552M / 18.500M--
--2022/Q218.346M / 21.503M--
Jun 23, 20222022/Q118.236M / 23.600M--
Mar 17, 20222021/Q422.071M / 24.087M--
DatePeriodRevenue/EstimateEarnings Call
--2022/Q412.798M / 18.100M--
--2022/Q317.552M / 18.500M--
--2022/Q218.346M / 21.503M--
Jun 23, 20222022/Q118.236M / 23.600M--
Mar 17, 20222021/Q422.071M / 24.087M--

Unlock Free Earnings Estimates

Redhill Biopharma Earnings Reports

Read more

Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.